Suijia Luo

发表

Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs–EBP interaction recover NAFLD through enhancing mitochondrial function in mice

Xianxing Jiang, Qian Zhao, Hongjiao Xu, 2022, Acta pharmaceutica Sinica. B.

Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis

Xi Sun, Zhongdao Wu, Xianxing Jiang, 2021, Acta pharmaceutica Sinica. B.

Design and Discovery of Novel Cyclic Peptides as EDPs-EBP Interaction Inhibitors for the Treatment of Liver Fibrosis.

Xianxing Jiang, Qian Zhao, Nazi Song, 2023, Journal of medicinal chemistry.

Discovery of Novel Peptide Antagonists Targeting GPR55 for Liver Inflammation and Fibrosis.

Nazi Song, Shuohan Wu, Xiaoqing Cai, 2024, Journal of medicinal chemistry.